Regulus Therapeutics (RGLS) PT Lowered to $0.42 at Wedbush

January 21, 2022 6:28 AM EST Send to a Friend

Wedbush analyst Liana Moussatos lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Regulus Therapeutics (RGLS) PT Lowered to $0.42 at Wedbush

Member Login

Free News Feed